|
1
|
Xu ZQ, Zhou Y, Shao BZ, Zhang JJ and Liu
C: A Systematic Review of Neuroprotective Efficacy and Safety of
DL-3-N-Butylphthalide in Ischemic Stroke. Am J Chin Med.
47:507–525. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Chinese Society of Cerebral Blood Flow and
Metabolism: The Chinese guidelines for the evaluation and
management of cerebral collateral circulation in ischemic stroke
(2017). Zhonghua Nei Ke Za Zhi 56: 460-471, 2017 (In Chinese).
|
|
3
|
Banks JL and Marotta CA: Outcomes validity
and reliability of the modified Rankin scale: implications for
stroke clinical trials: a literature review and synthesis. Stroke.
38:1091–1096. 2007.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Heldner MR, Zubler C, Mattle HP, Schroth
G, Weck A, Mono ML, Gralla J, Jung S, El-Koussy M, Lüdi R, et al:
National Institutes of Health stroke scale score and vessel
occlusion in 2152 patients with acute ischemic stroke. Stroke.
44:1153–1157. 2013.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Cui LY, Zhu YC, Gao S, Wang JM, Peng B, Ni
J, Zhou LX, He J and Ma XQ: Ninety-day administration of
dl-3-n-butylphthalide for acute ischemic stroke: A randomized,
double-blind trial. Chin Med J (Engl). 126:3405–3410.
2013.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Zhao H, Yun W, Zhang Q, Cai X, Li X, Hui
G, Zhou X and Ni J: Mobilization of Circulating Endothelial
Progenitor Cells by dl-3-n-Butylphthalide in Acute Ischemic Stroke
Patients. J Stroke Cerebrovasc Dis. 25:752–760. 2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Zhang C, Zhao S, Zang Y, Gu F, Mao S, Feng
S, Hu L and Zhang C: The efficacy and safety of
Dl-3n-butylphthalide on progressive cerebral infarction: A
randomized controlled STROBE study. Medicine (Baltimore).
96(e7257)2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Huang L, Wang S, Ma F, Zhang Y and Peng Y,
Xing C, Feng Y, Wang X and Peng Y: From stroke to neurodegenerative
diseases: The multi-target neuroprotective effects of
3-n-butylphthalide and its derivatives. Pharmacol Res. 135:201–211.
2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Skaper SD, Facci L, Zusso M and Giusti P:
An Inflammation-Centric View of Neurological Disease: Beyond the
Neuron. Front Cell Neurosci. 12(72)2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Liu J and Wang F: Role of
Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular
Mechanisms and Therapeutic Implications. Front Immunol.
8(1005)2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Niu F, Sharma A, Feng L, Ozkizilcik A,
Muresanu DF, Lafuente JV, Tian ZR, Nozari A and Sharma HS:
Nanowired delivery of DL-3-n-butylphthalide induces superior
neuroprotection in concussive head injury. Prog Brain Res.
245:89–118. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Zhang Y, Huang LJ, Shi S, Xu SF, Wang XL
and Peng Y: L-3-n-butylphthalide Rescues Hippocampal Synaptic
Failure and Attenuates Neuropathology in Aged APP/PS1 Mouse Model
of Alzheimer's Disease. CNS Neurosci Ther. 22:979–987.
2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Wang CY, Xu Y, Wang X, Guo C, Wang T and
Wang ZY: Dl-3-n-Butylphthalide Inhibits NLRP3 Inflammasome and
Mitigates Alzheimer's-Like Pathology via Nrf2-TXNIP-TrX Axis.
Antioxid Redox Signal. 30:1411–1431. 2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Yang M, Dang R, Xu P, Guo Y, Han W, Liao D
and Jiang P: Dl-3-n-Butylphthalide improves
lipopolysaccharide-induced depressive-like behavior in rats:
Involvement of Nrf2 and NF-κB pathways. Psychopharmacology (Berl).
235:2573–2585. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Zhao CY, Lei H, Zhang Y, Li L, Xu SF, Cai
J, Li PP, Wang L, Wang XL and Peng Y: L-3-n-Butylphthalide
attenuates neuroinflammatory responses by downregulating JNK
activation and upregulating Heme oxygenase-1 in
lipopolysaccharide-treated mice. J Asian Nat Prod Res. 18:289–302.
2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Chen Y, Jiang M, Li L, Ye M, Yu M, Zhang
L, Ge B, Xu W and Wei D: DL-3-n-butylphthalide reduces microglial
activation in lipopolysaccharide-induced Parkinson's disease model
mice. Mol Med Rep. 17:3884–3890. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zhao Y, Lee JH, Chen D, Gu X, Caslin A, Li
J, Yu SP and Wei L: DL-3-n-butylphthalide induced neuroprotection,
regenerative repair, functional recovery and psychological benefits
following traumatic brain injury in mice. Neurochem Int. 111:82–92.
2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Zhu J, Zhang Y and Yang C: Protective
effect of 3-n-butylphthalide against hypertensive nephropathy in
spontaneously hypertensive rats. Mol Med Rep. 11:1448–1454.
2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Wang Y, Bi Y, Xia Z, Shi W, Li B, Li B,
Chen L and Guo L: Butylphthalide ameliorates experimental
autoimmune encephalomyelitis by suppressing PGAM5-induced
necroptosis and inflammation in microglia. Biochem Biophys Res
Commun. 497:80–86. 2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Chen J, Wang J, Zhang J and Pu C: Effect
of butylphthalide intervention on experimental autoimmune myositis
in guinea pigs. Exp Ther Med. 15:152–158. 2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhang P, Guo ZF, Xu YM, Li YS and Song JG:
N-Butylphthalide (NBP) ameliorated cerebral ischemia
reperfusion-induced brain injury via HGF-regulated TLR4/NF-κB
signaling pathway. Biomed Pharmacother. 83:658–666. 2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Liu CY, Zhao ZH, Chen ZT, Che CH, Zou ZY,
Wu XM, Chen SG, Li YX, Lin HB, Wei XF, et al: DL-3-n-butylphthalide
protects endothelial cells against advanced glycation end
product-induced injury by attenuating oxidative stress and
inflammation responses. Exp Ther Med. 14:2241–2248. 2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Schapira AHV: Mitochondrial diseases.
Lancet. 379:1825–1834. 2012.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Arun S, Liu L and Donmez G: Mitochondrial
Biology and Neurological Diseases. Curr Neuropharmacol. 14:143–154.
2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Hybertson BM, Gao B, Bose SK and McCord
JM: Oxidative stress in health and disease: The therapeutic
potential of Nrf2 activation. Mol Aspects Med. 32:234–246.
2011.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Tan BL, Norhaizan ME, Liew WP and Sulaiman
Rahman H: Antioxidant and Oxidative Stress: A Mutual Interplay in
Age-Related Diseases. Front Pharmacol. 9(1162)2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Abdoulaye IA and Guo YJ: A Review of
Recent Advances in Neuroprotective Potential of 3-N-Butylphthalide
and Its Derivatives. BioMed Res Int. 2016(5012341)2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Yang XD, Cen ZD, Cheng HP, Shi K, Bai J,
Xie F, Wu HW, Li BB and Luo W: L-3-n-Butylphthalide Protects HSPB8
K141N Mutation-Induced Oxidative Stress by Modulating the
Mitochondrial Apoptotic and Nrf2 Pathways. Front Neurosci.
11(402)2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Liu Z, Wang H, Shi X, Li L, Zhou M, Ding
H, Yang Y, Li X and Ding K: DL-3-n-Butylphthalide (NBP) Provides
Neuroprotection in the Mice Models After Traumatic Brain Injury via
Nrf2-ARE Signaling Pathway. Neurochem Res. 42:1375–1386.
2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Li Q, Cheng Y, Bi M, Lin H, Chen Y, Zou Y,
Liu Y, Kang H and Guo Y: Effects of N-butylphthalide on the
activation of Keap1/Nrf-2 signal pathway in rats after carbon
monoxide poisoning. Environ Toxicol Pharmacol. 40:22–29.
2015.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Zhu BL, Xie CL, Hu NN, Zhu XB and Liu CF:
Inhibiting of GRASP65 Phosphorylation by DL-3-N-Butylphthalide
Protects against Cerebral Ischemia-Reperfusion Injury via ERK
Signaling. Behav Neurol. 2018(5701719)2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Wang S, Huang L, Zhang Y and Peng Y, Wang
X and Peng Y: Protective Effects of L-3-n-Butylphthalide Against
H2O2-Induced Injury in Neural Stem Cells by Activation of PI3K/Akt
and Mash1 Pathway. Neuroscience. 393:164–174. 2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Chen J, Wang J, Zhang J and Pu C:
3-n-Butylphthalide reduces the oxidative damage of muscles in an
experimental autoimmune myositis animal model. Exp Ther Med.
14:2085–2093. 2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Tian X, He W, Yang R and Liu Y:
Dl-3-n-butylphthalide protects the heart against ischemic injury
and H9c2 cardiomyoblasts against oxidative stress: Involvement of
mitochondrial function and biogenesis. J Biomed Sci.
24(38)2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Booth LA, Tavallai S, Hamed HA,
Cruickshanks N and Dent P: The role of cell signalling in the
crosstalk between autophagy and apoptosis. Cell Signal. 26:549–555.
2014.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Wang YG, Li Y, Wang CY, Ai JW, Dong XY,
Huang HY, Feng ZY, Pan YM, Lin Y, Wang BX, et al:
L-3-n-Butylphthalide protects rats' cardiomyocytes from
ischaemia/reperfusion-induced apoptosis by affecting the
mitochondrial apoptosis pathway. Acta Physiol (Oxf). 210:524–533.
2014.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Lei H, Zhao CY, Liu DM, Zhang Y, Li L,
Wang XL and Peng Y: l-3-n-Butylphthalide attenuates
β-amyloid-induced toxicity in neuroblastoma SH-SY5Y cells through
regulating mitochondrion-mediated apoptosis and MAPK signaling. J
Asian Nat Prod Res. 16:854–864. 2014.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Xu J, Huai Y, Meng N, Dong Y, Liu Z, Qi Q,
Hu M, Fan M, Jin W and Lv P: L-3-n-Butylphthalide Activates
Akt/mTOR Signaling, Inhibits Neuronal Apoptosis and Autophagy and
Improves Cognitive Impairment in Mice with Repeated Cerebral
Ischemia-Reperfusion Injury. Neurochem Res. 42:2968–2981.
2017.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Xiang J, Pan J, Chen F, Zheng L, Chen Y,
Zhang S and Feng W: L-3-n-butylphthalide improves cognitive
impairment of APP/PS1 mice by BDNF/TrkB/PI3K/AKT pathway. Int J
Clin Exp Med. 7:1706–1713. 2014.PubMed/NCBI
|
|
40
|
Iurlaro R and Muñoz-Pinedo C: Cell death
induced by endoplasmic reticulum stress. FEBS J. 283:2640–2652.
2016.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Liao D, Xiang D, Dang R, Xu P, Wang J, Han
W, Fu Y, Yao D, Cao L and Jiang P: Neuroprotective Effects of
dl-3-n-Butylphthalide against Doxorubicin-Induced
Neuroinflammation, Oxidative Stress, Endoplasmic Reticulum Stress,
and Behavioral Changes. Oxid Med Cell Longev.
2018(9125601)2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Niu XL, Jiang X, Xu GD, Zheng GM, Tang ZP,
Yin N, Li XQ, Yang YY and Lv PY: DL-3-n-butylphthalide alleviates
vascular cognitive impairment by regulating endoplasmic reticulum
stress and the Shh/Ptch1 signaling-pathway in rats. J Cell Physiol.
234:12604–12614. 2018.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Zheng B, Zhou Y, Zhang H, Yang G, Hong Z,
Han D, Wang Q, He Z, Liu Y, Wu F, et al: Dl-3-n-butylphthalide
prevents the disruption of blood-spinal cord barrier via inhibiting
endoplasmic reticulum stress following spinal cord injury. Int J
Biol Sci. 13:1520–1531. 2017.PubMed/NCBI View Article : Google Scholar
|
|
44
|
He Z, Zhou Y, Huang Y, Wang Q, Zheng B,
Zhang H, Li J, Liu Y, Wu F, Zhang X, et al: Dl-3-n-butylphthalide
improves functional recovery in rats with spinal cord injury by
inhibiting endoplasmic reticulum stress-induced apoptosis. Am J
Transl Res. 9:1075–1087. 2017.PubMed/NCBI
|
|
45
|
Nonaka T, Masuda-Suzukake M and Hasegawa
M: Molecular mechanisms of the co-deposition of multiple
pathological proteins in neurodegenerative diseases.
Neuropathology. 38:64–71. 2018.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Goedert M: NEURODEGENERATION. Alzheimer's
and Parkinson's diseases: The prion concept in relation to
assembled Aβ, tau, and α-synuclein. Science.
349(1255555)2015.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Peng Y, Sun J, Hon S, Nylander AN, Xia W,
Feng Y, Wang X and Lemere CA: L-3-n-butylphthalide improves
cognitive impairment and reduces amyloid-beta in a transgenic model
of Alzheimer's disease. J Neurosci. 30:8180–8189. 2010.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Peng Y, Hu Y, Xu S, Li P, Li J, Lu L, Yang
H, Feng N, Wang L and Wang X: L-3-n-butylphthalide reduces tau
phosphorylation and improves cognitive deficits in
AβPP/PS1-Alzheimer's transgenic mice. J Alzheimers Dis. 29:379–391.
2012.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Huang JZ, Chen YZ, Su M, Zheng HF, Yang
YP, Chen J and Liu CF: dl-3-n-Butylphthalide prevents oxidative
damage and reduces mitochondrial dysfunction in an MPP(+)-induced
cellular model of Parkinson's disease. Neurosci Lett. 475:89–94.
2010.PubMed/NCBI View Article : Google Scholar
|
